1. Figure 5. Tissue uptake of circulating 125I-β2-m.
Figure 5. Tissue uptake of circulating 125I-β2-m. Three, 6, and 14 h after 125I-β2-m injection into the cell-implanted and control nephrectomized mice, implanted cell tumor and other organs were obtained (n = 5 or 6 for each time specified in both cell-implanted and control groups). The 125I counts per weight of the implanted cell tumor (T), liver (Li), lung (Lu), heart (H), and skeletal muscle (S) are indicated. Uptake by the implanted cell tumor was significantly higher than in other tissues at all time points (Cell-impl.; *P < 0.05). The 125I counts in the heart, lung, liver, and skeletal muscle were not significantly different between the cell-implanted and control (Cont.) groups.
Akihiko Saito et al. JASN 2003;14:
©2003 by American Society of Nephrology